Renata De Maria Selected Research

Renata De Maria Research Topics

Disease

39	Heart Failure 12/2022 - 12/2002
3	Obesity 06/2021 - 01/2020
3	Inflammation (Inflammations) 01/2021 - 01/2017
3	COVID-19 11/2020 - 10/2020
3	Left Ventricular Dysfunction 07/2019 - 09/2007
3	Systolic Heart Failure 12/2008 - 05/2006
2	Heart Diseases (Heart Disease) 02/2024 - 11/2005
2	Pneumonia (Pneumonitis) 11/2020 - 11/2020
2	Insulin Resistance 01/2020 - 01/2020
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2018 - 07/2007
2	Coronary Disease (Coronary Heart Disease) 01/2018 - 03/2012
2	ST Elevation Myocardial Infarction 01/2018 - 01/2017
2	Anterior Wall Myocardial Infarction 01/2018 - 01/2017
2	Chronic Disease (Chronic Diseases) 04/2015 - 05/2010
2	Hyperemia 10/2014 - 04/2013
2	CADASIL 10/2014 - 01/2013
1	Cicatrix (Scar) 12/2022
1	Fatty Liver 01/2020
1	Magnesium Deficiency (Deficiency, Magnesium) 01/2020
1	Acute Coronary Syndrome 05/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2018
1	Myocarditis (Carditis) 04/2018
1	Malnutrition (Nutritional Deficiencies) 04/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Ventricular Remodeling 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 06/2017
1	REM Sleep Behavior Disorder 11/2016
1	Autonomic Nervous System Diseases (Dysautonomia) 11/2016
1	Olfaction Disorders (Cacosmia) 11/2016
1	Parkinson Disease (Parkinson's Disease) 11/2016
1	Cachexia 04/2015
1	Hypoxia (Hypoxemia) 04/2015
1	Hypercapnia 04/2015
1	Disease Progression 04/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2015
1	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2014

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2016
5	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2019 - 05/2006
4	Glutathione (Reduced Glutathione)IBA 01/2021 - 09/2006
4	Cysteine (L-Cysteine)FDA Link 01/2021 - 04/2007
4	DiureticsIBA 12/2018 - 06/2003
4	Sulfhydryl Compounds (Thiols)IBA 12/2007 - 09/2006
3	Natriuretic PeptidesIBA 01/2021 - 10/2013
3	AntioxidantsIBA 01/2021 - 01/2013
2	NeopterinIBA 06/2021 - 07/2010
2	Oxidants (Oxidizing Agents)IBA 01/2021 - 01/2013
2	HomocysteineIBA 01/2021 - 04/2007
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2020 - 11/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2020
2	Galectin 3 (LGALS3)IBA 01/2018 - 01/2017
2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 05/2014
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 11/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2013 - 10/2007
2	InterleukinsIBA 04/2013 - 07/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 12/2007
2	CytokinesIBA 07/2010 - 10/2007
2	Malondialdehyde (Propanedial)IBA 04/2007 - 09/2006
1	Vitamin D FDA LinkGeneric 01/2021
1	MyostatinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AdiponectinIBA 01/2021
1	LeptinIBA 01/2021
1	MagnesiumIBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Calcineurin InhibitorsIBA 01/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2018
1	Neprilysin (Neutral Endopeptidase)IBA 10/2018
1	Enalapril FDA LinkGeneric 10/2018
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2018
1	Tocolytic Agents (Tocolytics)IBA 04/2018
1	ProlactinIBA 04/2018
1	LDL CholesterolIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	SodiumIBA 01/2016
1	Oxygen (Dioxygen)IBA 04/2015
1	Genetic Markers (Genetic Marker)IBA 12/2014
1	sapropterin (tetrahydrobiopterin)FDA Link 10/2014
1	Free RadicalsIBA 01/2013
1	3-nitrotyrosineIBA 01/2013

Therapy/Procedure

11	Therapeutics 02/2024 - 07/2009
5	Heart-Assist Devices 05/2022 - 07/2010
4	Cardiac Resynchronization Therapy 12/2022 - 10/2012
3	Defibrillators (Defibrillator) 12/2022 - 02/2010
3	Heart Transplantation (Grafting, Heart) 05/2022 - 01/2016
3	Cardiac Rehabilitation 02/2019 - 03/2015
3	Patient Readmission 10/2015 - 05/2005
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2012 - 08/2003
2	Ambulatory Care (Outpatient Care) 05/2019 - 07/2016
2	Percutaneous Coronary Intervention 01/2018 - 01/2017
2	Continuity of Patient Care 01/2016 - 05/2010
2	Palliative Care (Palliative Therapy) 04/2015 - 12/2012
1	Drug Therapy (Chemotherapy) 11/2022
1	Critical Care (Surgical Intensive Care) 05/2019
1	Secondary Prevention 01/2018
1	Continuous Positive Airway Pressure 06/2017
1	Noninvasive Ventilation 06/2017
1	Length of Stay 10/2015